Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 May 5;10(1):177.
doi: 10.1186/s13104-017-2499-7.

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency

Affiliations
Case Reports

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency

Suleiman Al-Hammadi et al. BMC Res Notes. .

Abstract

Background: The Bacillus Calmette-Guérin (BCG) preparations are live-attenuated derivatives of Mycobacterium bovis. These products are used to vaccinate infants at birth, a practice that may result in a disseminated infection in those patients who have an unidentified immunodeficiency.

Case presentation: Patients who were immunized at birth with BCG and who developed a disseminated infection are reported here to emphasize the importance of taking an extensive medical history before ‎giving the BCG vaccine. Patient 1 has a sibling who had familial hemophagocytic lymphohistiocytosis. Patient 2 has a severe immunodeficiency with profound lymphopenia. Patient 3 has a sibling who had a disseminated BCG infection. Patient 4 has two siblings with an immunodeficiency disorder; one sibling passed away in infancy and one is receiving regular immunoglobulin infusions. Patient 5 has profound lymphopenia and his brother had cytomegalovirus (CMV) pneumonitis and passed away in infancy.

Conclusions: These unfortunate events could have been avoided by compiling the relevant clinical and laboratory information. These cases also underscore the importance of a strict adherence to the BCG vaccine policies. Local and international registries that estimate the birth prevalence of primary immune deficiencies are needed prior to implementing universal BCG vaccination administration.

Keywords: BCG; Danish-SSI 1331 strain; Immunodeficiency; Mycobacterium bovis; Newborns; Tuberculosis; Vaccines.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Case 1. a skin lesions showing erythematous nodules. b, c H&E stain of a skin excisional lesion ‎showing infiltration by histiocytes in the dermis. d, e H&E stain of marrow biopsy, showing infiltration by histiocytes. f marrow specimen revealing infiltration by histiocytes ingesting acid-fast bacilli
Fig. 2
Fig. 2
Case 2. a (age 9 months): chest x-ray at her initial presentation showing bilateral pneumonia. b left forearm image showing her well-defined erythematous to brownish scaly plaques of different sizes. c (age 24 months): multiple cystic TB lesions with ring enhancements are evident; one in the right parietal lobe (measuring 48 × 45 mm and associated with edema and compression of the ipsilateral lateral ventricle) and one in the left parietal lobe (measuring 33 × 23 mm). Other smaller lesions are seen scattered on both cerebral hemispheres. d, e (age 32 months): decrease in the size of these lesions as well as decrease in the thick enhancement of their peripheral walls following treatment
Fig. 3
Fig. 3
Case 3. BCG vaccine-associated chronic (recurrent) cervical lymphadenitis since birth

Similar articles

Cited by

References

    1. Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine. 1999;17:915–922. doi: 10.1016/S0264-410X(98)00277-1. - DOI - PubMed
    1. Behr MA. BCG—different strains, different vaccines? Lancet Infect Dis. 2002;2:86–92. doi: 10.1016/S1473-3099(02)00182-2. - DOI - PubMed
    1. Aguirre-Blanco AM, Lukey PT, Cliff JM, Dockrell HM. Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro. Infect Immun. 2007;75:3197–3201. doi: 10.1128/IAI.01611-06. - DOI - PMC - PubMed
    1. Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev. 2008;32:821–841. doi: 10.1111/j.1574-6976.2008.00118.x. - DOI - PubMed
    1. Bolger T, O’Connell M, Menon A, Butler K. Complications associated with the bacille Calmette-Gue´rin vaccination in Ireland. Arch Dis Child. 2006;91:594–597. doi: 10.1136/adc.2005.078972. - DOI - PMC - PubMed

Publication types